Income Statement HealthCare Global Enterprises Limited

Equities

HCG

INE075I01017

Healthcare Facilities & Services

Market Closed - NSE India S.E. Other stock markets 06:58:38 2026-03-06 am EST			5-day change	1st Jan Change
555.30 ^INR	+2.50%		-3.54%	-16.12%

Feb. 24	Healthcare Global Enterprises rights issue up to 4.25 bln rupees approved	RE
Feb. 17	Healthcare Global Enterprises approves equity shares issuance for 4.25 billion rupees	RE

5d74ef2dca01e42070745049422956f.fqmeWlZo90HWIUGVq4oH2AuDaD1XbI5J6Y7PvgL-2VU.L5quLwU6oQqMFSLNyrpFijzaGW9mOvQPm8GhjmuboWwHmvAqBFmkKp55Kg

Published financial data: HEALTHCARE GLOBAL ENTERPRISES LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	10.09B	13.95B	16.91B	19.08B	22.18B
Other Revenues, Total	42.5M	30.05M	30.33M	42.48M	47.14M
Total Revenues	10.13B	13.98B	16.94B	19.12B	22.23B
Cost of Goods Sold, Total	4.86B	6.46B	7.75B	8.65B	10.32B
Gross Profit	5.27B	7.52B	9.2B	10.48B	11.91B
Selling General & Admin Expenses, Total	190M	274M	448M	620M	732M
Provision for Bad Debts	-	-	317M	4.32M	97.27M
Depreciation & Amortization - (IS)	1.59B	1.58B	1.63B	1.74B	2.11B
Other Operating Expenses	3.83B	4.87B	5.44B	6.55B	7.19B
Other Operating Expenses, Total	5.61B	6.73B	7.84B	8.92B	10.13B
Operating Income	-334M	795M	1.36B	1.55B	1.78B
Interest Expense, Total	-1.14B	-831M	-905M	-979M	-1.44B
Interest And Investment Income	156M	116M	118M	127M	159M
Net Interest Expenses	-981M	-715M	-786M	-852M	-1.28B
Income (Loss) On Equity Invest.	-3.65M	-14.25M	-180K	3.88M	7.71M
Currency Exchange Gains (Loss)	-26.22M	-290K	-17.56M	650K	-2.94M
Other Non Operating Income (Expenses)	-8.89M	-129M	-95.47M	-77.2M	68.37M
EBT, Excl. Unusual Items	-1.35B	-63.19M	456M	630M	568M
Restructuring Charges	-	-	-	-	-
Merger & Related Restructuring Charges	-	-5.5M	-	-	-
Impairment of Goodwill	-130M	-	-	-	-
Gain (Loss) On Sale Of Investments	1.4M	1.24M	350K	2.17M	1.57M
Gain (Loss) On Sale Of Assets	-510K	-6.43M	-13.22M	-17.74M	-10.64M
Asset Writedown	-304M	-467M	-	-	-
Legal Settlements	-	-	-	-	-
Other Unusual Items	-500M	1.42B	6.13M	63.03M	10.24M
EBT, Incl. Unusual Items	-2.29B	878M	449M	677M	570M
Income Tax Expense	-75.61M	488M	272M	264M	81.3M
Earnings From Continuing Operations	-2.21B	389M	176M	413M	488M
Net Income to Company	-2.21B	389M	176M	413M	488M
Minority Interest	276M	148M	117M	68.21M	-44.24M
Net Income - (IS)	-1.93B	537M	293M	482M	444M
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	-1.93B	537M	293M	482M	444M
Net Income to Common Excl. Extra Items	-1.93B	537M	293M	482M	444M
Per Share Items
Net EPS - Basic	-17.02	4.14	2.11	3.46	3.19
Basic EPS - Continuing Operations	-17.02	4.14	2.11	3.46	3.19
Basic Weighted Average Shares Outstanding	114M	130M	139M	139M	139M
Net EPS - Diluted	-17.02	3.97	2.1	3.43	3.14
Diluted EPS - Continuing Operations	-17.02	3.97	2.1	3.43	3.14
Diluted Weighted Average Shares Outstanding	114M	135M	140M	140M	141M
Normalized Basic EPS	-5.01	0.84	2.89	3.32	2.23
Normalized Diluted EPS	-5.01	0.8	2.88	3.29	2.2
Supplemental Items
EBITDA	656M	1.78B	2.37B	2.67B	3.13B
EBITA	-334M	806M	1.38B	1.58B	1.85B
EBIT	-334M	795M	1.36B	1.55B	1.78B
EBITDAR	710M	1.88B	2.48B	2.89B	3.4B
Total Revenues (As Reported)	10.3B	14.1B	17.08B	19.29B	22.58B
Effective Tax Rate - (Ratio)	3.31	55.65	60.72	38.97	14.27
Current Domestic Taxes	-	-	-	-	-
Total Current Taxes	47.1M	237M	154M	343M	287M
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	-123M	251M	119M	-79.2M	-205M
Normalized Net Income	-569M	109M	402M	462M	311M
Interest Capitalized	62.42M	28.83M	720K	5.25M	110M
Interest on Long-Term Debt	1.11B	818M	859M	930M	1.34B
Non-Cash Pension Expense	7.89M	7.82M	10.13M	15.18M	18.32M
Supplemental Operating Expense Items
Advertising Expense	-	-	-	-	-
Marketing Expenses	136M	181M	336M	401M	463M
Selling and Marketing Expenses	136M	181M	336M	401M	463M
Net Rental Expense, Total	53.84M	92.8M	112M	218M	269M
Imputed Operating Lease Interest Expense	44.44M	67.46M	88.98M	158M	215M
Imputed Operating Lease Depreciation	9.4M	25.34M	22.57M	60.26M	54.26M
Maintenance & Repair Expenses, Total	490M	564M	745M	794M	960M
Stock-Based Comp., COGS (Total)	19.12M	31.03M	65.14M	78.46M	64.79M
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	19.12M	31.03M	65.14M	78.46M	64.79M

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	300M	1.98B	1.75B	2.73B	2.36B
Short Term Investments	1.36B	66.42M	220M	305M	1.12B
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	1.66B	2.04B	1.97B	3.03B	3.48B
Accounts Receivable, Total	2.02B	2.4B	3.03B	2.94B	4.01B
Other Receivables	36.99M	12.87M	52.67M	39.87M	35.96M
Notes Receivable	93.06M	16.08M	17.69M	19.43M	26.96M
Total Receivables	2.15B	2.43B	3.1B	3B	4.07B
Inventory	211M	300M	383M	427M	530M
Prepaid Expenses	56.78M	60.05M	54.69M	65.48M	78.53M
Other Current Assets, Total	276M	194M	304M	276M	280M
Total Current Assets	4.35B	5.02B	5.8B	6.8B	8.44B
Gross Property Plant And Equipment	18.03B	20.11B	21.72B	25.39B	30.77B
Accumulated Depreciation	-5.08B	-6.53B	-8.01B	-9.5B	-10.89B
Net Property Plant And Equipment	12.95B	13.58B	13.71B	15.89B	19.88B
Long-term Investments	383M	242M	227M	190M	321M
Goodwill	963M	1.81B	1.81B	2.23B	4.3B
Other Intangibles, Total	215M	298M	187M	299M	489M
Loans Receivable Long-Term	451M	-	-	-	-
Deferred Tax Assets Long-Term	343M	59.57M	52.74M	70.58M	250M
Other Long-Term Assets, Total	706M	1.18B	1.37B	1.6B	1.76B
Total Assets	20.36B	22.2B	23.16B	27.07B	35.43B
Liabilities
Accounts Payable, Total	1.46B	1.94B	2.48B	2.81B	3.34B
Accrued Expenses, Total	401M	524M	574M	611M	712M
Short-term Borrowings	675M	48.18M	34.37M	1.07B	2.83B
Current Portion of Long-Term Debt	584M	399M	342M	809M	1.15B
Current Portion of Leases	365M	411M	488M	428M	599M
Current Income Taxes Payable	3.52M	5.31M	24.68M	21.98M	26.37M
Unearned Revenue Current, Total	30.71M	28.51M	28.92M	37.08M	55.51M
Other Current Liabilities	1.14B	1.34B	1.73B	1.65B	1.75B
Total Current Liabilities	4.65B	4.7B	5.7B	7.44B	10.46B
Long-Term Debt	3.46B	3.63B	3.62B	4.85B	6.05B
Long-Term Leases	4.69B	4.66B	4.53B	5.59B	7.75B
Unearned Revenue Non Current	280M	255M	359M	328M	387M
Pension & Other Post Retirement Benefits	86.21M	105M	132M	157M	214M
Deferred Tax Liability Non Current	42.77M	12.79M	124M	60.75M	35.35M
Other Non Current Liabilities	-	-	-	-	634M
Total Liabilities	13.22B	13.36B	14.47B	18.42B	25.53B
Common Stock, Total	1.25B	1.39B	1.39B	1.39B	1.39B
Additional Paid In Capital	9.97B	11.63B	11.65B	11.69B	11.72B
Retained Earnings	-4.75B	-4.37B	-4.52B	-4.96B	-4.09B
Comprehensive Income and Other	495M	49.25M	87.66M	139M	203M
Total Common Equity	6.97B	8.7B	8.61B	8.26B	9.22B
Minority Interest	168M	134M	88.94M	393M	676M
Total Equity	7.14B	8.84B	8.69B	8.65B	9.9B
Total Liabilities And Equity	20.36B	22.2B	23.16B	27.07B	35.43B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	125M	139M	139M	139M	139M
ECS Total Common Shares Outstanding	125M	139M	139M	139M	139M
Book Value / Share	55.61	62.61	61.86	59.29	66.17
Tangible Book Value	5.79B	6.59B	6.61B	5.73B	4.44B
Tangible Book Value Per Share	46.22	47.42	47.49	41.14	31.82
Total Debt	9.78B	9.15B	9.01B	12.74B	18.37B
Net Debt	8.12B	7.11B	7.05B	9.71B	14.9B
Debt Equivalent of Unfunded Proj. Benefit Obligation	131M	153M	182M	217M	258M
Debt Equivalent Oper. Leases	431M	742M	892M	1.75B	2.15B
Minority Interest, Total (Incl. Fin. Div)	168M	134M	88.94M	393M	676M
Equity Method Investments, Total	205M	30.13M	28.51M	33.6M	43.09M
Account Code - Inventory Valuation	3	6	6	6	6
Inventories - Finished Goods, Total	-	-	383M	427M	530M
Land - (BS)	403M	637M	647M	647M	1.03B
Buildings, Total	775M	1.48B	1.48B	2.01B	2.06B
Machinery, Total	9.41B	10.02B	11.31B	12.01B	13.85B
Full Time Employees	5.45K	5.68K	6.13K	6.15K	6.74K
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	479M	629M	465M	686M	792M

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	-1.93B	537M	293M	482M	444M
Depreciation & Amortization - CF	1.47B	1.46B	1.52B	1.67B	1.98B
Amortization of Goodwill and Intangible Assets - (CF)	-	10.07M	23.6M	24.33M	71.78M
Depreciation & Amortization, Total	1.47B	1.47B	1.54B	1.69B	2.06B
Amortization of Deferred Charges, Total - (CF)	120M	109M	90.85M	52.92M	56.86M
(Gain) Loss From Sale Of Asset	520K	6.43M	13.22M	17.74M	10.64M
(Gain) Loss on Sale of Investments - (CF)	-1.4M	-1.5B	-350K	-2.17M	-1.57M
Asset Writedown & Restructuring Costs	434M	472M	-	-	-
(Income) Loss On Equity Investments - (CF)	3.65M	14.25M	180K	-3.88M	-7.76M
Stock-Based Compensation (CF)	19.12M	31.03M	65.14M	78.46M	65.44M
Provision and Write-off of Bad Debts	67.53M	151M	163M	230M	204M
Other Operating Activities, Total	474M	1.01B	805M	572M	1.11B
Change In Accounts Receivable	-78.48M	-404M	-785M	-278M	-908M
Change In Inventories	21.5M	-60.75M	-83.14M	-39.51M	-96.13M
Change In Accounts Payable	529M	443M	563M	99.38M	295M
Change in Other Net Operating Assets	78.75M	-82.97M	-154M	-53.58M	-56.42M
Cash from Operations	1.21B	2.2B	2.52B	2.85B	3.17B
Capital Expenditure	-354M	-712M	-1.33B	-1.86B	-2.09B
Sale of Property, Plant, and Equipment	610K	7.91M	75.59M	17.01M	15.44M
Cash Acquisitions	-64M	-1.17B	-20M	-485M	-1.97B
Divestitures	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-2.88B	3.01B	-132M	-14.3M	-927M
Other Investing Activities, Total	1.59B	114M	78.62M	82.07M	94.48M
Cash from Investing	-1.71B	1.25B	-1.33B	-2.26B	-4.88B
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	724M	1.95B	554M	2.9B	2.22B
Total Debt Issued	724M	1.95B	554M	2.9B	2.22B
Short Term Debt Repaid, Total	-31.23M	-	-	-	-
Long-Term Debt Repaid, Total	-2.75B	-3.78B	-1.01B	-1.97B	-1.04B
Total Debt Repaid	-2.78B	-3.78B	-1.01B	-1.97B	-1.04B
Issuance of Common Stock	4.53B	1.32B	8.86M	19.49M	15.58M
Other Financing Activities, Total	-1.34B	-1.04B	-956M	-1.59B	-1.62B
Cash from Financing	1.12B	-1.55B	-1.4B	-640M	-424M
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	617M	1.9B	-215M	-51.64M	-2.13B
Supplemental Items
Cash Interest Paid	1.13B	933M	956M	1.17B	1.58B
Cash Income Tax Paid (Refund)	-380M	237M	227M	474M	319M
Levered Free Cash Flow	-390M	1.4B	795M	689M	-139M
Unlevered Free Cash Flow	320M	1.92B	1.36B	1.3B	763M
Change In Net Working Capital	728M	-521M	-146M	-365M	439M
Net Debt Issued / Repaid	-2.06B	-1.83B	-453M	933M	1.18B

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	-0.97	2.34	3.74	3.87	3.56
Return on Total Capital	-1.21	2.85	4.75	4.97	4.48
Return On Equity %	-39	4.87	2.01	4.77	5.26
Return on Common Equity	-35.88	6.86	3.39	5.71	5.08
Margin Analysis
Gross Profit Margin %	52.04	53.8	54.28	54.78	53.58
SG&A Margin	1.87	1.96	2.64	3.24	3.29
EBITDA Margin %	6.48	12.76	14	13.97	14.08
EBITA Margin %	-3.29	5.76	8.14	8.26	8.33
EBIT Margin %	-3.29	5.69	8	8.13	8.01
Income From Continuing Operations Margin %	-21.82	2.78	1.04	2.16	2.2
Net Income Margin %	-19.09	3.84	1.73	2.52	2
Net Avail. For Common Margin %	-19.09	3.84	1.73	2.52	2
Normalized Net Income Margin	-5.62	0.78	2.37	2.42	1.4
Levered Free Cash Flow Margin	-3.85	10.01	4.69	3.61	-0.63
Unlevered Free Cash Flow Margin	3.16	13.73	8.03	6.81	3.43
Asset Turnover
Asset Turnover	0.47	0.66	0.75	0.76	0.71
Fixed Assets Turnover	0.71	1.05	1.24	1.29	1.24
Receivables Turnover (Average Receivables)	5.01	6.32	6.24	6.4	6.38
Inventory Turnover (Average Inventory)	21.91	25.28	22.7	21.36	21.57
Short Term Liquidity
Current Ratio	0.93	1.07	1.02	0.91	0.81
Quick Ratio	0.8	0.95	0.88	0.81	0.72
Operating Cash Flow to Current Liabilities	0.26	0.47	0.44	0.38	0.3
Days Sales Outstanding (Average Receivables)	72.88	57.8	58.53	57.22	57.18
Days Outstanding Inventory (Average Inventory)	16.66	14.44	16.08	17.14	16.92
Average Days Payable Outstanding	112.8	94.64	103.11	111.52	107.75
Cash Conversion Cycle (Average Days)	-23.26	-22.41	-28.51	-37.16	-33.65
Long Term Solvency
Total Debt/Equity	136.96	103.5	103.66	147.3	185.57
Total Debt / Total Capital	57.8	50.86	50.9	59.56	64.98
LT Debt/Equity	114.21	93.78	93.72	120.69	139.35
Long-Term Debt / Total Capital	48.2	46.08	46.02	48.8	48.8
Total Liabilities / Total Assets	64.92	60.18	62.46	68.05	72.06
EBIT / Interest Expense	-0.29	0.96	1.5	1.59	1.23
EBITDA / Interest Expense	1	2.73	3.2	3.31	2.66
(EBITDA - Capex) / Interest Expense	0.69	1.87	1.73	1.42	1.21
Total Debt / EBITDA	8.59	4.03	3.11	3.93	4.79
Net Debt / EBITDA	7.14	3.13	2.43	2.99	3.88
Total Debt / (EBITDA - Capex)	12.47	5.88	5.75	9.18	10.51
Net Debt / (EBITDA - Capex)	10.36	4.56	4.5	6.99	8.52
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-7.5	37.93	21.22	12.85	16.25
Gross Profit, 1 Yr. Growth %	-13.83	42.6	22.3	13.89	13.69
EBITDA, 1 Yr. Growth %	-45.73	171.88	32.97	12.6	17.15
EBITA, 1 Yr. Growth %	-241.37	-341.36	71.17	14.53	17.23
EBIT, 1 Yr. Growth %	-245.44	-338.35	70.37	14.73	14.45
Earnings From Cont. Operations, 1 Yr. Growth %	76.24	-117.6	-54.71	134.45	18.14
Net Income, 1 Yr. Growth %	81.32	-127.77	-45.38	64.08	-7.78
Normalized Net Income, 1 Yr. Growth %	1.83	-119.08	270.12	14.92	-32.65
Diluted EPS Before Extra, 1 Yr. Growth %	41.27	-123.32	-47.1	63.33	-8.45
Accounts Receivable, 1 Yr. Growth %	0.28	18.89	26.09	-2.8	36.35
Inventory, 1 Yr. Growth %	-9.24	41.99	27.74	11.45	24.27
Net Property, Plant and Equip., 1 Yr. Growth %	-16.52	4.88	0.99	15.84	25.13
Total Assets, 1 Yr. Growth %	-9.66	9.03	4.35	16.9	30.87
Tangible Book Value, 1 Yr. Growth %	141.49	13.79	0.21	-13.27	-22.58
Common Equity, 1 Yr. Growth %	82.86	24.83	-1.12	-4.04	11.71
Cash From Operations, 1 Yr. Growth %	-7.39	82.64	14.3	13.11	11.43
Capital Expenditures, 1 Yr. Growth %	-67.14	101.08	87.05	39.36	12.49
Levered Free Cash Flow, 1 Yr. Growth %	-71.7	-458.89	-43.22	-13.26	-120.2
Unlevered Free Cash Flow, 1 Yr. Growth %	-152.83	499.08	-29.13	-4.31	-41.41
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	1.76	12.95	29.31	16.96	14.54
Gross Profit, 2 Yr. CAGR %	-4.22	10.85	32.06	18.02	13.79
EBITDA, 2 Yr. CAGR %	-26.49	21.47	90.14	22.36	14.85
EBITA, 2 Yr. CAGR %	-8.46	84.72	103.26	40.02	15.87
EBIT, 2 Yr. CAGR %	-8.21	86.19	101.51	39.81	14.59
Earnings From Cont. Operations, 2 Yr. CAGR %	167.6	-44.3	-71.76	3.05	66.43
Net Income, 2 Yr. CAGR %	179.32	-29.03	-61.05	-5.33	23.01
Normalized Net Income, 2 Yr. CAGR %	95.04	-55.93	-15.98	106.24	-12.03
Diluted EPS Before Extra, 2 Yr. CAGR %	145.66	-42.6	-64.88	-7.05	22.28
Accounts Receivable, 2 Yr. CAGR %	8.05	9.19	22.44	10.7	15.12
Inventory, 2 Yr. CAGR %	-11.21	13.52	34.68	19.31	17.68
Net Property, Plant and Equip., 2 Yr. CAGR %	13.54	-6.43	2.92	8.16	20.4
Total Assets, 2 Yr. CAGR %	10.95	-0.75	6.67	10.45	23.69
Tangible Book Value, 2 Yr. CAGR %	27.22	65.76	6.78	-6.77	-18.06
Common Equity, 2 Yr. CAGR %	20.94	51.09	11.1	-2.59	3.54
Cash From Operations, 2 Yr. CAGR %	10.61	30.06	44.48	13.7	12.27
Capital Expenditures, 2 Yr. CAGR %	-56.68	-18.72	93.94	61.45	25.21
Levered Free Cash Flow, 2 Yr. CAGR %	52.72	0.79	42.75	-29.82	-58.14
Unlevered Free Cash Flow, 2 Yr. CAGR %	46.98	77.9	106.05	-17.65	-25.12
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	6.85	12.62	15.64	23.57	16.72
Gross Profit, 3 Yr. CAGR %	2.99	9.37	14.54	25.7	16.56
EBITDA, 3 Yr. CAGR %	-17.34	13.68	25.19	59.67	20.6
EBITA, 3 Yr. CAGR %	-10.89	26.46	80.09	67.88	31.97
EBIT, 3 Yr. CAGR %	-10.75	26.17	80.76	67.02	30.79
Earnings From Cont. Operations, 3 Yr. CAGR %	135.46	8.03	-48.01	-42.82	7.85
Net Income, 3 Yr. CAGR %	111.24	29.4	-34.96	-37.1	-6.15
Normalized Net Income, 3 Yr. CAGR %	67.18	-10.14	-10.42	-6.73	42.02
Diluted EPS Before Extra, 3 Yr. CAGR %	92.67	12.07	-44.14	-41.37	-7.52
Accounts Receivable, 3 Yr. CAGR %	12.66	11.55	14.56	13.37	18.66
Inventory, 3 Yr. CAGR %	-4.22	3.84	18.07	26.44	20.94
Net Property, Plant and Equip., 3 Yr. CAGR %	13.45	10.58	-4.02	7.06	13.55
Total Assets, 3 Yr. CAGR %	12.14	10.31	0.92	9.97	16.87
Tangible Book Value, 3 Yr. CAGR %	13.15	22.57	40.16	-0.37	-12.37
Common Equity, 3 Yr. CAGR %	10.62	22.22	31.17	5.81	1.96
Cash From Operations, 3 Yr. CAGR %	7.21	30.74	24.57	33.16	12.94
Capital Expenditures, 3 Yr. CAGR %	-48.29	-27.74	7.31	73.71	43.13
Levered Free Cash Flow, 3 Yr. CAGR %	-42.68	103.04	-16.76	20.91	-53.66
Unlevered Free Cash Flow, 3 Yr. CAGR %	-44.19	134.78	30.9	59.56	-26.48
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	11.65	14.83	15.32	14.33	15.2
Gross Profit, 5 Yr. CAGR %	10.69	13.07	13.76	12.75	14.24
EBITDA, 5 Yr. CAGR %	-4.77	11.39	15.35	17.08	20.95
EBITA, 5 Yr. CAGR %	-3.88	10.97	23.93	31.72	50.97
EBIT, 5 Yr. CAGR %	-3.88	10.69	23.62	31.46	50.63
Earnings From Cont. Operations, 5 Yr. CAGR %	150.56	11.05	0.8	6.01	-17.2
Net Income, 5 Yr. CAGR %	165.7	19.37	7.42	14.2	-16.08
Normalized Net Income, 5 Yr. CAGR %	174.35	-11.03	26.96	25.28	-11.06
Diluted EPS Before Extra, 5 Yr. CAGR %	47.46	8.1	-2.47	3.99	-23.58
Accounts Receivable, 5 Yr. CAGR %	20.11	15.94	16.47	11.21	14.78
Inventory, 5 Yr. CAGR %	9.6	9.81	9.77	9.77	17.92
Net Property, Plant and Equip., 5 Yr. CAGR %	15.12	12.15	9.12	9.61	5.09
Total Assets, 5 Yr. CAGR %	14.3	12.6	9.91	10.36	9.48
Tangible Book Value, 5 Yr. CAGR %	9.85	12.55	10.56	9.86	13.08
Common Equity, 5 Yr. CAGR %	10.36	15	10.81	11.62	19.33
Cash From Operations, 5 Yr. CAGR %	10.49	19.25	20.8	23.64	19.5
Capital Expenditures, 5 Yr. CAGR %	-29.97	-18.04	-12.26	-0.33	14.14
Levered Free Cash Flow, 5 Yr. CAGR %	-11.88	16.85	-17.43	32.75	-36.77
Unlevered Free Cash Flow, 5 Yr. CAGR %	-8.89	29.86	-5.89	54.41	4.69